BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li F, Aljahdali IAM, Zhang R, Nastiuk KL, Krolewski JJ, Ling X. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma. J Exp Clin Cancer Res 2021;40:254. [PMID: 34384473 DOI: 10.1186/s13046-021-02026-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Li Y, Xiong J. The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease. Molecules 2022;27:7318. [DOI: 10.3390/molecules27217318] [Reference Citation Analysis]
2 Tanvir I, Hassan A, Albeladi F. DNA Methylation and Epigenetic Events Underlying Renal Cell Carcinomas. Cureus 2022. [DOI: 10.7759/cureus.30743] [Reference Citation Analysis]
3 Li Y, Du Y, Zhang Y, Chen C, Zhang J, Zhang X, Zhang M, Yan Y. Machine learning algorithm-based identification and verification of characteristic genes in acute kidney injury. Front Med (Lausanne) 2022;9:1016459. [PMID: 36313991 DOI: 10.3389/fmed.2022.1016459] [Reference Citation Analysis]
4 Li H, Sun X, Li J, Liu W, Pan G, Mao A, Liu J, Zhang Q, Rao L, Xie X, Sheng X. Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway. Neoplasia 2022;32:100821. [PMID: 35985176 DOI: 10.1016/j.neo.2022.100821] [Reference Citation Analysis]
5 Shlyapnikov YM, Malakhova EA, Potoldykova NV, Svetocheva YA, Vinarov AZ, Zinchenko DV, Zernii EY, Zamyatnin AA, Shlyapnikova EA. Non-Invasive Diagnostics of Renal Cell Carcinoma Using Ultrasensitive Immunodetection of Cancer-Retina Antigens. Biochemistry Moscow 2022;87:658-666. [DOI: 10.1134/s0006297922070070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Angori S, Lobo J, Moch H. Papillary renal cell carcinoma: current and controversial issues. Curr Opin Urol 2022;32:344-51. [PMID: 35674688 DOI: 10.1097/MOU.0000000000001000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Swiatkowska A. p53 and Its Isoforms in Renal Cell Carcinoma—Do They Matter? Biomedicines 2022;10:1330. [DOI: 10.3390/biomedicines10061330] [Reference Citation Analysis]
8 Hao W, Li M, Cai Q, Wu S, Li X, He Q, Hu Y. Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches. Front Physiol 2022;13:889792. [DOI: 10.3389/fphys.2022.889792] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ye B, Peng X, Su D, Liu D, Huang Y, Huang Y, Pang Y. Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension. Clin Exp Hypertens 2022;:1-10. [PMID: 35507763 DOI: 10.1080/10641963.2022.2071919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yu R, Zhou Y, Shi S, Wang X, Huang S, Ren Y. Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p/GPX4 axis. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154182] [Reference Citation Analysis]
11 Wang S, Wei X, Ji C, Wang Y, Zhang X, Cong R, Song N. Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis. Front Oncol 2022;12:781932. [PMID: 35356208 DOI: 10.3389/fonc.2022.781932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhang XZ, Chen MJ, Fan PM, Jiang W, Liang SX. BTG2 Serves as a Potential Prognostic Marker and Correlates with Immune Infiltration in Lung Adenocarcinoma. IJGM 2022;Volume 15:2727-45. [DOI: 10.2147/ijgm.s340565] [Reference Citation Analysis]
13 Chen Y, Jia Y, Li Y, Zheng Y, Chen G, Shi Y. Investigation on the antitumor effects of paeonol against renal cell carcinoma based on network pharmacology and experimental validation. J Ethnopharmacol 2022;285:114857. [PMID: 34813895 DOI: 10.1016/j.jep.2021.114857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 He M, Li M, Guan Y, Wan Z, Tian J, Xu F, Zhou H, Gao M, Bi H, Chong T. A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma. Front Genet 2022;12:820154. [DOI: 10.3389/fgene.2021.820154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]